Evaluation of serum and salivary PCSK9 and IL6 and its association with periodontal inflammation and atherosclerotic cardiovascular diseases
- PMID: 36042970
- PMCID: PMC9420378
- DOI: 10.1016/j.jobcr.2022.08.013
Evaluation of serum and salivary PCSK9 and IL6 and its association with periodontal inflammation and atherosclerotic cardiovascular diseases
Erratum in
-
Erratum regarding missing declaration of competing interest statements in previously published articles.J Oral Biol Craniofac Res. 2024 Jul-Aug;14(4):358-359. doi: 10.1016/j.jobcr.2024.05.010. Epub 2024 May 22. J Oral Biol Craniofac Res. 2024. PMID: 38826840 Free PMC article.
Abstract
Background: and Purpose: The aim of this study was to assess, compare and correlate the ability of PCSK9 and IL6 as potential common serum and salivary biomarkers for stage III/IV periodontitis and the risk of developing atherosclerotic cardiovascular diseases.
Methods: 76 patients were alloted into 4 groups consisting of subjects with clinically healthy periodontium and stage III/IV periodontitis with and without ACVD. Clinical parameters - PD, CAL, number of teeth, PI, mSBI, TC, Tg, HDL and LDL were recorded. Serum and saliva samples were obtained and subjected to ELISA for quantifying the biomarker levels.
Results: The level of these biomarkers was found to be the lowest (IL6 Serum: 21.92 ± 14.54, IL6 Saliva: 12.34 ± 7.72, PCSK9 Serum: 178.82 ± 35.07, PCSK9 Saliva: 80.82 ± 25.43) in group I and highest in group IV (IL6 Serum: 73.4 ± 24.86, IL6 Saliva: 37.66 ± 15.77, PCSK9 Serum: 346.54 ± 45.11, PCSK9 Saliva: 157.72 ± 43.28). The clinical parameters PI, mSBI, PPD, CAL, total number of teeth, TC, HDL and LDL showed a significant correlation with biomarkers PCSK9 and IL6.
Conclusion: This study features the elevation of serum and salivary PCSK9 and IL6 in periodontitis and ACVD. A triad of serum and salivary PCSK9 and IL6 along with the clinical markers of periodontal disease can relatively predict the future risk of developing ACVD.
Keywords: Atherosclerotic cardiovascular disease; Biomarkers; Chronic inflammation; IL6; PCSK9; Periodontal disease.
© 2022 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.
Figures
References
-
- Balaji S., Cholan P.K., Victor D.J. Evaluation of “soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), interleukin-1β, and matrix metalloproteinase-8” as a short panel of salivary biomarkers in patients with and without stage III/IV periodontitis and type 2 diabetes mellitus. J Oral Biol Craniofacial Res. 2022;12(1):33–37. doi: 10.1016/j.jobcr.2021.10.003. [Internet] Available from: - DOI - PMC - PubMed
-
- Pahwa R., Jialal I. Atherosclerosis. 2022. Treasure Island (FL)
-
- Momtazi-Borojeni A.A., Sabouri-Rad S., Gotto A.M., et al. PCSK9 and inflammation: a review of experimental and clinical evidence. Eur Hear J - Cardiovasc Pharmacother. 2019;5(4):237–245. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous